Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 05  •  04:00PM ET
0.3745
Dollar change
-0.0120
Percentage change
-3.10
%
Dec 05, 4:37 PMCo-Diagnostics shareholders approved reverse stock split authorization at a special meeting today, per SEC filing.
Index- P/E- EPS (ttm)-0.96 Insider Own8.95% Shs Outstand60.89M Perf Week1.05%
Market Cap22.80M Forward P/E- EPS next Y-0.41 Insider Trans0.00% Shs Float55.44M Perf Month-4.49%
Enterprise Value12.83M PEG- EPS next Q-0.12 Inst Own15.42% Short Float3.08% Perf Quarter20.65%
Income-32.18M P/S44.71 EPS this Y43.55% Inst Trans0.37% Short Ratio0.07 Perf Half Y24.79%
Sales0.51M P/B0.45 EPS next Y42.14% ROA-54.95% Short Interest1.71M Perf YTD-50.07%
Book/sh0.83 P/C1.99 EPS next 5Y31.42% ROE-62.12% 52W High1.55 -75.84% Perf Year-57.44%
Cash/sh0.19 P/FCF- EPS past 3/5Y- -27.40% ROIC-79.35% 52W Low0.23 64.62% Perf 3Y-87.56%
Dividend Est.- EV/EBITDA- Sales past 3/5Y-80.11% 29.07% Gross Margin-201.52% Volatility10.79% 11.56% Perf 5Y-96.80%
Dividend TTM- EV/Sales25.16 EPS Y/Y TTM29.16% Oper. Margin-6995.70% ATR (14)0.06 Perf 10Y-
Dividend Ex-Date- Quick Ratio3.51 Sales Y/Y TTM-87.84% Profit Margin-6336.27% RSI (14)49.90 Recom2.00
Dividend Gr. 3/5Y- - Current Ratio3.81 EPS Q/Q51.13% SMA203.87% Beta1.20 Target Price1.50
Payout- Debt/Eq0.04 Sales Q/Q-29.73% SMA50-4.86% Rel Volume0.03 Prev Close0.39
Employees132 LT Debt/Eq0.02 EarningsNov 13 AMC SMA2005.66% Avg Volume24.53M Price0.37
IPOJul 12, 2017 Option/ShortYes / Yes EPS/Sales Surpr.15.79% -51.53% Trades Volume825,799 Change-3.10%
Date Action Analyst Rating Change Price Target Change
Aug-12-22Downgrade Sidoti Buy → Neutral $5
Dec-29-21Initiated Sidoti Buy $14
Mar-29-21Downgrade Maxim Group Buy → Hold
May-20-20Upgrade Maxim Group Hold → Buy
May-18-20Reiterated H.C. Wainwright Buy $20 → $35
Mar-09-20Reiterated H.C. Wainwright Buy $4 → $20
Mar-03-20Downgrade Maxim Group Buy → Hold
Dec-02-25 12:00PM
Nov-20-25 09:00AM
Nov-18-25 09:00AM
Nov-14-25 12:02AM
Nov-13-25 05:15PM
04:01PM Loading…
04:01PM
Nov-12-25 05:55PM
09:00AM
Nov-10-25 08:45AM
Nov-06-25 05:20PM
Nov-05-25 09:00AM
Nov-04-25 06:15PM
Nov-03-25 09:00AM
Oct-31-25 09:00AM
Oct-30-25 01:57PM
12:51PM Loading…
Oct-29-25 12:51PM
Oct-28-25 09:33AM
Oct-27-25 08:45AM
08:30AM
Oct-22-25 08:30AM
Oct-16-25 09:30AM
Oct-13-25 09:30AM
Sep-30-25 09:30AM
Sep-18-25 05:05PM
Sep-17-25 09:47AM
09:35AM
Sep-16-25 09:30AM
Sep-11-25 09:30AM
Sep-09-25 09:30AM
Aug-18-25 10:30AM
09:30AM Loading…
09:30AM
Aug-15-25 10:30AM
03:23AM
Aug-14-25 05:15PM
04:01PM
Aug-13-25 09:40AM
Aug-11-25 10:21AM
Aug-07-25 06:20PM
Aug-06-25 08:15AM
Jul-31-25 09:30AM
Jul-15-25 09:30AM
Jul-11-25 08:02AM
May-30-25 09:31AM
May-14-25 09:30AM
May-09-25 03:41AM
May-08-25 07:10PM
04:01PM
May-07-25 07:35PM
05:35PM
Apr-29-25 07:30AM
Apr-02-25 12:00PM
Mar-28-25 08:45AM
03:03AM
Mar-27-25 07:05PM
06:44PM
04:01PM
Mar-19-25 05:20PM
Mar-13-25 09:30AM
Mar-06-25 03:30PM
Mar-03-25 09:30AM
Feb-24-25 08:18AM
Feb-21-25 04:00PM
Jan-30-25 09:30AM
Jan-07-25 09:30AM
Dec-10-24 09:30AM
Nov-08-24 10:03AM
Nov-07-24 04:01PM
Nov-05-24 09:30AM
Oct-25-24 04:01PM
Oct-21-24 09:30AM
Oct-09-24 05:58PM
Oct-02-24 09:30AM
Sep-24-24 09:30AM
Sep-05-24 09:30AM
Aug-15-24 09:30AM
Aug-08-24 04:01PM
Jul-29-24 09:30AM
Jul-25-24 09:30AM
Jul-02-24 09:30AM
Jun-18-24 01:30PM
Jun-14-24 09:30AM
May-10-24 01:16PM
May-09-24 08:58PM
04:01PM
Apr-25-24 09:30AM
Apr-24-24 09:30AM
Apr-12-24 09:30AM
Apr-04-24 09:30AM
Mar-21-24 09:30AM
Mar-18-24 09:30AM
Mar-15-24 03:21PM
05:45AM
Mar-14-24 08:55PM
04:01PM
Mar-07-24 09:30AM
Feb-29-24 09:30AM
Feb-01-24 09:30AM
Jan-03-24 09:30AM
Dec-27-23 09:30AM
Nov-29-23 09:30AM
Co-Diagnostics, Inc. engages in the development and innovation of molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications. Its diagnostics systems enable very rapid, low-cost, molecular testing for organisms and genetic diseases by automating historically complex procedures in both the development and administration of tests. The company was founded by Brent C. Satterfield and Dwight Howard Egan on April 18, 2013 and is headquartered in Salt Lake City, UT.